Product Details:
Payment & Shipping Terms:
|
Effect: | Lose Weight / Fat Loss / Cutting Weight | CAS: | 1379686-30-2 |
---|---|---|---|
M.F: | C20H24ClN3O4S | M.W.: | 437.94 |
High Light: | weight loss sarms,fat burning sarms |
Details of SR9009
Superlist Name: SR9009
SR9009 Molecular Formula: C20H24ClN3O4S
SR9009 CAS No.: 1379686-30-2
SR9009 Purity: 99%
SR9009 Synonyms: Ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate
SR9009 Molecular Weight: 437.94
SR9009 Appearance: White powder
SR9009 Solubility: DMSO
SR9009 Port: SH
SR9009 Application: SR9009 increase exercise endurance and loss weight.
Skype:Wendy.Doublewin
Email:doublewin-wendy@nandrolonesteroid.com
SR9009 has great promise in increased exercise capacity and endurance. This compound acts as an agonist of Rev-erbα. SR9009 binds to one of the body’s natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation. Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in both culture and in mice. The treated mice had a 50 percent increase in running capacity, measured by both time and distance.
SR9009 has great promise in increased exercise capacity and endurance. This compound acts as an agonist of Rev-erbα. SR9009 binds to one of the body’s natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation. Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in both culture and in mice. The treated mice had a 50 percent increase in running capacity, measured by both time and distance.
Easy to dose oral compound that boosts metabolic activity in current studies
SR9009 latches onto Rev-erbα -- which plays a role in regulating the body's circadian rhythm and metabolism -- resulting in a pronounced metabolic boost in test subjects.
Research may lead to new approaches to helping people with conditions that acutely limit exercise tolerance
SR9009 affects the primary biological clock, which coordinates the rhythm of the body’s activity with the 24-hour phase of day and night.
Recent research show that activation of Rev-erbα with SR9009 resulted to enhanced metabolic activity in skeletal muscle tissue in both culture and in mice. The authors of this new research propose that Rev-erbα affects muscle cells by stimulating both the formation of new mitochondria (more known as the “power plants” of the cell) and the authorization of those mitochondria that are flawed.
If the effects of SR9009 on mice can securely be duplicated for people, the new drug may provide new treatments for obesity and its companions, metabolic syndrome and diabetes. Another area in which SR9009 or a similar drug may present significant benefit is to balance the loss of overall muscle conditioning which transpires as a side effect of reduced activity due to sickness or old age.
SR9009 Good Effects
1. | SR9009 will help a person become leaner, and it will help them do more distance with cardio without getting winded as fast. |
2. | SR9009 has the ability to alter the activity of the skeletal muscle mitochondria, or in simple terms - it boosts your metabolic activity. This makes it similar to what DNP does, being SR9009 much safer and not counter productive to your endurance goals. |
3. | SR9009 has the ability to mimic actual aerobic exercise without actually putting in the conditioning. |
4. | SR9009 can benefit non athletes as well, since it can reverse obesity, metabolic syndrome, and type 2 diabetes. |
5. | SR9009 does not act like a fat burner, thyroid accelerator, or appetite suppressant such as T3, Therefore, you won't experience a crash or feel tired on it |
SARMs
Name | CAS NO. | Usage |
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 | for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one |
AC262356 | 870888-46-3 | New SARMS |
SR9011 | 1379686-29-9 | New SARMS |
S23 | 1010396-29-8 | New SARMS |
GW0724 | 317318-84-6 | New SARMS |
Contact Person: Doublewin-daisy
Tel: +8617507260306